How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04348227

Enrollment

120

Registered

2020-04-16

Start date

2019-01-01

Completion date

2021-02-04

Last updated

2020-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia

Brief summary

A previous study showed a high incidence of ventilator-associated pneumonia to multidrug resistant pathogens in our ICU. That has been related to lack of compliance to hand hygiene among health care providers in ou ICU.

Detailed description

A single-center cohort study performed in the department of Anesthesia and Intensive Care in our Hospital. All endotracheal isolates realised in the period of study are collected from the Department of Microbiology of our Hospital.

Interventions

BEHAVIORALEnhanced hygiene measures

Wether or not hygiene measures dictated by the pandemic of severe acute respiratory syndrome coronavirus 19 , reduce multi drug resistant pathogens isolated in endotracheal aspirates.

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients requiring mechanical ventilation for more than 24 hours

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
MDR pathogens in endotracheal aspirates	1 year	Incidence of MDR bacteria in endotracheal aspirates

Secondary

Measure	Time frame	Description
Microorganisms in endotracheal aspirates	1 year	Incidence of microorganisms in endotracheal aspirates

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026